Benzimidazole treatment of cystic echinococcosis

Acta Tropica

Volumn 85, Issue 2, 2003, Pages 243-252

  El On, Joseph ^a  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

Benzimidazoles; Cystic echinococcosis; Immune response; Susceptibility and drug resistance

Indexed keywords

ALBENDAZOLE SULFOXIDE; ALCOHOL; BENZIMIDAZOLE DERIVATIVE; FLUBENDAZOLE; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G4; MEBENDAZOLE; PARASITE ANTIGEN; PRAZIQUANTEL; SODIUM CHLORIDE; SULFATE; TIABENDAZOLE;

DISEASE TREATMENT;

ABDOMINAL PAIN; BINDING AFFINITY; CELLULAR IMMUNITY; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; CONFERENCE PAPER; DIARRHEA; DIGESTIVE SYSTEM FUNCTION DISORDER; DOSE RESPONSE; DRUG ABSORPTION; DRUG ACTIVITY; DRUG BIOAVAILABILITY; DRUG COST; DRUG EFFICACY; DRUG EXCRETION; DRUG INHIBITION; DRUG MECHANISM; DRUG MEGADOSE; DRUG METABOLISM; DRUG SAFETY; DRUG TOLERANCE; ECHINOCOCCOSIS; ECHINOCOCCUS GRANULOSUS; EMBRYOTOXICITY; EOSINOPHILIA; ERYTHROCYTE SEDIMENTATION RATE; FOLLOW UP; GLUCOSE TRANSPORT; GOLD THERAPY; HEADACHE; HEMATURIA; HUMAN; HUMORAL IMMUNITY; INTESTINE ABSORPTION; LEUKOPENIA; LIVER DYSFUNCTION; LIVER HYDATID CYST; LONG TERM CARE; MALAISE; NAUSEA; NEMATODIASIS; NONHUMAN; PARASITE DEVELOPMENT; PROGNOSIS; RECURRENT DISEASE; TREATMENT OUTCOME; VERTIGO; VOMITING;

ALBENDAZOLE; ANIMALS; ANTIBODY FORMATION; BENZIMIDAZOLES; DRUG RESISTANCE; DRUG THERAPY, COMBINATION; ECHINOCOCCOSIS; ECHINOCOCCUS; HUMANS; IMMUNITY, CELLULAR; LEUKOCYTES, MONONUCLEAR; MEBENDAZOLE; PRAZIQUANTEL; TREATMENT OUTCOME;

EID: 0037327720     PISSN: 0001706X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0001-706X(02)00217-6     Document Type: Conference Paper

References (64)

1. Ammann R., Eckert J. Clinical diagnosis and treatment of echinococcosis in humans. Thompson R.C.A., Limbery A.J. Echinococcus and Hydatid Disease. 1995;411-463 CAB International, Wallingford, UK.
2. Andrews P. Praziquantel - a novel schistosomicide. Parasitology. 75:1977;17-18.
3. Bartoloni C., Tricerri A., Guidi L., Gambassi G. The efficacy of chemotherapy with mebendazole in human cystic echinococcosis: long-term follow-up of 52 patients. Ann. Trop. Med. Parasitol. 86:1992;249-256.
4. Beard T.C., Rickard M.D., Goodman H.T. Medical treatment for hydatids. Med. J. Aust. 1:1978;633-635.
5. Bonifacino R., Carter S.D., Almeeida I., Da Rosa D. Assessment of the imunological surveillance value of humoral and lymphocyte assay in severe human cystic echinococcosis. Trans. R. Soc. Trop. Med. Hyg. 94:2000;97-102.
6. Brown D.H., Matzuk A.R., Ilves I.R., Peterson L.H., Harris S.A., Sarett L.H., Egerton J.R., Yakstis J.J., Campbell W.C., Cuckler A.C. Antiparasitic drugs. IV. 2-(4′-Thiazolyl)-benzimidazole, a new anthelmintic. J. Am. Chem. Soc. 83:1961;1764-1765.
7. Brugmans J.P., Thienpot D.C., yan Wijngaarden I., Vanparijs O.F., Schuermans V.L., Lauers H.L. Mebendazole in enterobiasis. Radiochemical and pilot clinical study in 1278 subjects. J. Am. Med. Assoc. 217:1971;313-316.
8. Bulut V., Ilhan F., Yucel A.H., Onal S., Ilhan Y., Godekmerdan A. Immunological follow-up of yhdatid cyst cases. Mem. Inst. Oswaldo Cruz Rio de Janeiro. 96:2001;669-671.
9. Casado N., Perez-Serrano J., Denegri G., Rodriguez-Caabeiro F. Development of a chemotherapeutic model for the in vitro screening of drugs against Echinococcus granulosus cysts: the effect of albendazole-albendazole sulphoxide combination. Int. J. Parasitol. 26:1996;59-65.
10. Craig P.S. Detection of specific circulating antigen, immune complexes and antibodies in human hydatidosis from Turkana (Kenya) and Great Britain, by enzyme immunoassay. Parasite Immunol. 8:1986;171-188.
11. Craig, P.S., 1997. Immunodiagnosis of Echinococcus granulosus. In: Anderson, F.L. (Ed.), Compendium on Cystic Echinococcosis in Africa and in Middle Eastern Countries with Special Reference to Morocco, Provo, Brigham Young University Print Services, UT84602, pp. 85-118.
12. Crippa F.G., Bruno R., Brunetti E., Filice C. Echinococcal liver cysts: treatment with echo-guided percutaneous puncture PAIR for echinococcal liver cysts. Ital. J. Gastroenterol. Hepatol. 31:1999;884-892.
13. Davis A., Dixon H., Pawlowski Z. Multicentre clinical trials of benzimidazole carbamates in human cystic echinococcosis (phase 2). Bull. World Health Organ. 67:1989;503-508.
14. Deger E., Hokelek M., Deger B.A., Tutar E., Asil M., Pakdemirli E. A new therapeutic approach for the treatment of cystic echinococcosis: percutaneous albendazole sulfoxide injection without reaspiration. Am. J. Gastroenterol. 95:2000;248-254.
15. Dematteis S., Baz A., Rottenberg M., Fernandez C., Orn A., Nieto A. Antibody and Th1/Th2-type responses in Balb/c mice inoculated with live or dead Echinococcus granulosus protoscoleces. Parasite Immunol. 21:1999;19-26.
16. Dematteis S., Pirotto F., Marques J., Nieto A., Orn A., Baz A. Modulation of the cellular immune response by a carbohydrate rich fraction from Echinococcus granulosus protoscoleces in infected or immunized Balb/c mice. Parasite Immunol. 23:2001;1-9.
17. De Rosa F., Teggi A. Treatment of Echinococcus granulosus hydatid disease with albendazole. Ann. Trop. Med. Parasitol. 84:1990;467-472.
18. Ellis M., Von Sinner W., Al-Hokail A., Sieck J. A clinical-radiological evaluation of benzimidazoles in the management of Echinococcus granulosus cysts. Scand. J. Infect. Dis. 24:1992;1-13.
19. El-On, J., Ben-Harush, A., Sneier, R., Peiser, J., 1997. A long-term immunological responses in hydatidosis patients after successfully surgical cyst removal combined with albendazole therapy. XVIII International Congress of Hydatidology, Lisbon, Portugal, p. 225.
20. Fierlafijn E. Mebendazole in enterobiasis. J. Am. Med. Assoc. 218:1971;1051.
21. Friedman P.A., Platzer E.G. Interaction of anthelmintic benzimidazoles with Ascaris suum embryonic tubulin. Biochim. Biophys. Acta. 630:1980;271-278.
22. Gollackner B., Langle F., Auer H., Maier A., Mittlbock M., Agstner I., Karner J., Langer F., Aspock H., Loidolt H., Rockenschaub S., Steininger R. Radical surgical therapy of abdominal cystic hydatid disease: factors of recurrences. World J. Surg. 24:2000;717-721.
23. Gottschall D.W., Theodorides V.J., Wang R. The metabolism of benzimidazole anthelmintics. Parasitol. Today. 6:1990;115-124.
24. Gyorkos, T.W., Larocque, R., 2001. Epidemiological evidence on benzimidazole use during pregnancy. 50th Annual Meeting of the American Society of Tropical Medicine and Hygiene, Atlanta, GA, p. 197.
25. Heath D.D. Immunology of Echinococcus infections. Thompson R.C.A., Limbery A.J. Echinococcus and Hydatid Disease. 1995;183-199 CAB International, Wallingford, UK.
26. Horton R.J. Chemotherapy of Echinococcus infection in man with albendazole. Trans. R. Soc. Trop. Med. 83:1989;97-102.
27. Horton R.J. Benzimidazoles in a wormy world. Parasitol. Today. 6:1990;106.
28. Jimenez-Mejias M.E., Alarcon-Cruz J.C., Marquez-Rivas F.J., Palomino-Nicas J., Montero J.M., Pachon J. Orbital hydatid cyst: Treatment and prevention of recurrences with albendazole plus praziquantel. J. Infect. 41:2000;105-107.
29. Keshmiri M., Baharvahdat H., Fattahi S.H., Da-vachi B., Dabiri R.H., Baradaran H., Ghiasi T., Rajabimashhadi M.T., Rajabzadeh F. A placebo controlled study of albendazole in the treatment of pulmonary echinococcosis. Eur. Respir. J. 14:1999;503-507.
30. Kharebov A., Nahmias J., El-On J. Cellular and humoral immune responses of hydatidosis patients to Echinococcus granulosus purified antigens. Am. J. Trop. Med. Hyg. 57:1997;619-625.
31. Korhonen M.H., Brunstein J., Haario H., Katnikov A., Rescaldani R., Hedman K. A new method with general diagnostic utility for the calculation of immnoglobulin G avitidy. Clin. Diagn. Lab. Immunol. 6:1999;725-728.
32. Lacey E. The role of the cycloskeletal protein, tubuline, in the mode of action and mechanism of drug resistance to benzimidazoles. Int. J. Parasitol. 18:1988;885-936.
33. Lacey E. Mode of action of benzimidazoles. Parasitol. Today. 6:1990;112-115.
34. Lacey E., Gill J.H. Biochemistry of benzimidazole resistance. Acta Trop. 56:1994;245-262.
35. Lacey E., Snowdon K.L. A routine diagnostic assay for the detection of benzimidazole resistance in parasitic nematodes using tritiated benzimidazole carbamates. Vet. Parasitol. 27:1988;309-324.
36. Leopold G.H., Ungethum W., Groll E., Diekmann H.W., Nowak H., Wegner D.H. Clinical pharmacology in normal volunteers of praziquantel, a new drug against schistosomes and cestodes. An example of a complex study covering both tolerance and pharmacokinetics. Eur. J. Clin. Pharmacol. 14:1978;281-291.
37. Lightowler M.W., Gottstein B. Echinococcosis/hydatidosis: antigens, immunological and molecular diagnosis. Thompson R.C.A., Limbery A.J. Echinococcus and Hydatid Disease. 1995;333-410 CAB International, Wallingford, UK.
38. Morris D.L. Pre-operative albendazole therapy for hydatid cyst. Br. J. Surg. 74:1987;805-806.
39. Morris D.L., Taylor D.H. Optimal tyming of post-operative albendazole prophylaxis in Echinococcus granulosus. Ann. Trop. Med. Parasitol. 82:1988;65-66.
40. Morris D.L., Dykes P.W., Marriner S., Bogan J., Burrows F., Skeene-Smith H., Clarkson M.J. Albendazole-objective evidence of response in human hydatid disease. J. Am. Med. Assoc. 253:1985;2053-2057.
41. Morris D.L., Chinnery J.B., Georgiou G., Golematis B., Stamatakis J., Hadcastle D.J. Penetration of albendazole sulfoxide into hydatid cysts. Gut. 28:1987;75-80.
42. Nahmias J., Goldsmith R., Soibelman M., El-On J. Three- to 7-year follow-up albendazole treatment of 68 patients with cystic echinococcosis (hydatid disease). Ann. Trop. Med. Parasitol. 88:1994;295-304.
43. Pelaez V., Kugler C., Correa D., Del Carpio M., Guangiroli M., Molina J., Marcos B., Lopez E. PAIR as percutaneous treatment of hydatid liver cysts. Acta Trop. 75:2000;197-202.
44. Pullen G.R., Fitzgerald M.G., Hosking C.S. Antibody avidity determination by ELISA using thiocyanate elution. J. Immunol. Methods. 86:1986;83-87.
45. Rigano R., Profumo E., Di Felice G., Ortona A., Teggi A., Siracusano A. In vitro production of cytokines by peripheral blood mononuclear cells from hydatid patients. Clin. Exp. Immunol. 99:1995;433-439.
46. Rigano R., Profumu E., Siracusano A. New perspectives in the immunology of Echinococcus granulosus infection. Parasitology. 39:1997;257-275.
47. Rigano R., Profumo E., Ioppolo S., Notargiacomo S., Teggi A., Siracusano A. Cytokine patterns in seropositive and seronegative patients with Echinococcus granulosus infection. Immunol. Let. 64:1998;5-8.
48. Rippman K., Dietrich M., Kern P. Long-term therapy of cystic liver echinococcosis with mebendazole. Medizin. Klin. 87:1992;350-354.
49. Roos M.H., Kwa M.S.G., Grant W.N. New genetic and practical implications of selection for antihelmintic resistance in parasitic nematodes. Parasitol. Today. 11:1995;148-150.
50. Saimot A.G., Meulemans A., Cremieux A.C., Giovanangeli M.D., Hay J.M., Delaitre B., Coulaud J.P. Albendazole as a potential treatment for human hydatidosis. Lancet. ii:1983;652-656.
51. Sheth U.K. Mechanisms of anthelmintic action. Prog. Drug Res. 19:1975;147-157.
52. Siracusano A., Teggi A., Quintieri F., Notargiacomo S., DeRosa F., Vicari G. Cellular immune responses of hydatid patients to Echinococcus granulosus antigens. Clin. Exp. Immunol. 72:1988;400-405.
53. Taylor D.H., Morris D.L. Combination chemotherapy is more effective in post-spillage prophylaxis for hydatid disease than either albendazole or praziquantel alone. Br. J. Surg. 76:1989;954.
54. Teggi A., Capozzi A., De Rosa F. Treatment of Echinococcus granulosus hydatid disease with mebendazole. J. Chemother. 1:1989;310-317.
55. Teggi A., Lastilla G.M., De Rosa F. Therapy of human hydatid disease with mebendazole and albendazole. Antimicrob. Agents chemother. 37:1993;1679-1684.
56. Thomas H., Andrews P. Praziquantel - a new cestocide. Pestic. Sci. 8:1977;556-560.
57. Thomas H., Gonnert R. The efficacy of praziquantel against cestodes in animals. Z. Parasitenkd. 52:1977;117-127.
58. Todorov T., Vutova K., Mechkov G., Petkov D., Nedelkov G., Tonchev Z. Evaluation of response to chemotherapy of human cystic echinococcosis. Br. J. Radiol. 63:1990;523-531.
59. Todorov T., Vutova K., Mechkov G., Georgiev P., Petskov D., Tonchev Z., Nedelkov G. Chemotherapy of human cystic echinococcosis; comparative efficacy of mebendazole and albendazole. Ann. Trop. Med. Parasitol. 86:1992;59-66.
60. Urrea-Paris M.A., Moreno M.J., Casado N., Rodriguez-Caabeiro F. Echinococcus granulosus: praziquantel treatment against the metacestode stage. Parasitol. Res. 85:1999;999-1006.
61. Urrea-Paris M.A., Moreno M.J., Casado N., Rodriguez-Caabeiro F. In vitro effect of praziquantel and albendazole combination therapy on the larval stage of Echinococcus granulosus. Parasitol. Res. 86:2000;957-964.
62. Vutova K., Mechkov G., Vachkov P., Petkov R., Georgiev P., Handjiev S., Ivanov A., Todorov T. Effect of mebendazole on human cystic echinococcosis: the role of dosage and treatment duration. Ann. Trop. Med. Parasitol. 93:1999;357-365.
63. Wilson J.F., Davidson M., Rausch R.L. A clinical trial of mebendazole in the treatment of alveolar hydatid disease. Am. Rev. Respir. Dis. 118:1978;747-757.
64. Yasaway M.I., Al-Karawi M.A., Mohamed A.R. Combination of praziquantel and albendazole in the treatment of hydatid disease. Trop. Med. Parasitol. 44:1993;192-194.